{"id":2112,"date":"2026-06-07T17:00:00","date_gmt":"2026-06-07T20:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2112"},"modified":"2026-06-07T17:00:00","modified_gmt":"2026-06-07T20:00:00","slug":"pgrss-colon-oncologica-avancada-hipec-crs-sugarbaker-lavagem-peritoneal-carcinomatose-citorreducao","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-colon-oncologica-avancada-hipec-crs-sugarbaker-lavagem-peritoneal-carcinomatose-citorreducao\/","title":{"rendered":"PGRSS colon HIPEC: CRS, Sugarbaker, lavagem"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente desafiada por gestores de centros de cir colon avan\u00e7ada. Em 2026, h\u00e1 uma demanda crescente de hospitais com unidade colon HIPEC \u2014 CRS Cytoreductive Surgery + HIPEC Hyperthermic IntraPeritoneal Chemotherapy<\/strong> segundo Sugarbaker para carcinomatose peritoneal de origem colorretal + ap\u00eandice + ov\u00e1rio + est\u00f4mago + mesotelioma peritoneal, CC0\/CC1 score Completeness of Cytoreduction<\/strong> ressec\u00e7\u00e3o completa m\u00e1xima sem doen\u00e7a residual ou <2.5mm + PCI Peritoneal Cancer Index 0-39 estadiamento, CRS multivisceral<\/strong> com ressec\u00e7\u00e3o peritoneal estendida + omentectomia greater + lesser + apendicectomia + colectomia + ressec\u00e7\u00e3o delgado + esplenectomia + colecistectomia + diafragma + Pelvic exenteration + ressec\u00e7\u00e3o de c\u00e1psula hep\u00e1tica + redu\u00e7\u00e3o de Glisson, HIPEC<\/strong> com cisplatina 50-100mg\/m\u00b2 + mitomicina C 12.5-15mg\/m\u00b2 + oxaliplatina 350-460mg\/m\u00b2 + irinotecano + paclitaxel + doxorrubicina (Lista C5) circuito intraperitoneal aquecido 41-43\u00b0C \u00d7 30-90min via Belmont Hyperthermic Pump<\/strong> ou Combat Pre-Heat<\/strong> ou Sunchrise Performer HT<\/strong> + Cell Saver autotransfus\u00e3o<\/strong> + EPI qu\u00edmico-t\u00e9rmico<\/strong>, Sugarbaker open Coliseum technique<\/strong> vs closed abdomen technique<\/strong> + PIPAC Pressurized IntraPeritoneal Aerosol Chemotherapy<\/strong> alternativa minimamente invasiva, EPIC Early Postoperative Intraperitoneal Chemotherapy<\/strong> complementar 5-FU paclitaxel intraperitoneal POD 1-5, lavagem peritoneal extensa<\/strong> SF 0.9% aquecido 4-8L com circula\u00e7\u00e3o cont\u00ednua + drenos abdominais 4-6 + monitoriza\u00e7\u00e3o hemodin\u00e2mica avan\u00e7ada, NIPS Neoadjuvant IntraPeritoneal Systemic chemotherapy<\/strong> + bevacizumab Avastin + cetuximab Erbitux + panitumumab Vectibix anti-EGFR Lista C5. A consequ\u00eancia \u00e9 a urg\u00eancia de PGRSS dedicado para colon HIPEC<\/strong> \u2014 captura de HIPEC Lista C5<\/strong> cisplatina+mitomicina C+oxaliplatina+irinotecano+paclitaxel+doxorrubicina (R$ 4-12k\/sess\u00e3o \u00d7 1 sess\u00e3o por CRS+HIPEC) + descarte espec\u00edfico citost\u00e1tico aquecido + EPI t\u00e9rmico-qu\u00edmico, circuito HIPEC descart\u00e1vel<\/strong> Belmont\/Combat\/Sunchrise R$ 4-12k\/circuito + bag de inflow\/outflow aquecido 41-43\u00b0C + sensor de temperatura, EPI HIPEC<\/strong> macac\u00e3o imperme\u00e1vel + capacete elastom\u00e9rico + face shield + luva nitr\u00edlica refor\u00e7ada 6-8mil + sapatilha + EPI qu\u00edmico N\u00edvel 4 quimioter\u00e1pico, Cell Saver autotransfus\u00e3o<\/strong> Sorin\/Haemonetics + filtro leucodepletivo + bag de coleta + descarte espec\u00edfico citost\u00e1tico no campo, bevacizumab Avastin + cetuximab Erbitux + panitumumab Vectibix<\/strong> Lista C5 R$ 8-25k\/dose neoadjuvante + cofre + cadeia fria + livro 344, cartucho EndoGIA Tri-Staple Medtronic<\/strong> R$ 800-2k \u00d7 8-15 cartuchos\/CRS + Endopath Xcel circular CDH<\/strong> R$ 1.500-3.500 + bisturi Harmonic ACE \/ LigaSure<\/strong> + CUSA Cavitron Integra<\/strong> R$ 3-25k + clip Hem-O-Lok L\/XL<\/strong> Teleflex, drenagem aspirativa<\/strong> Hemovac\/JP\/Pleur-evac \u00d7 4-6 drenos descart\u00e1vel + bolsa de coleta de efluente HIPEC. A realidade \u00e9 que colon HIPEC produz RSS de alt\u00edssima complexidade. PGRSS de colon HIPEC \u00e9 cadeia integrada<\/strong> \u2014 come\u00e7a no diagn\u00f3stico<\/strong> (CT trif\u00e1sica + RM + PET-CT + PCI score + biopsia + IHC + KRAS+NRAS+BRAF + MSI\/dMMR), passa pela terapia<\/strong> (NIPS neoadjuvante + CRS + HIPEC + EPIC) e termina na adjuv\u00e2ncia<\/strong> (FOLFOX + FOLFIRI + FOLFOXIRI + bev\/cetux\/panitumumab). O conjunto soma R$ 38.000-78.000\/m\u00eas<\/strong> que muitos gestores subestimam.<\/p>\n

Para o gestor que opera ou planeja unidade colon HIPEC, \u00e9 fundamental considerar a complexidade desde o in\u00edcio.<\/p>\n

Os procedimentos colon HIPEC e os RSS espec\u00edficos<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, a cadeia gera RSS espec\u00edficos.<\/p>\n\n\n\n\n\n\n\n\n\n
Procedimento<\/th>\nInsumo cr\u00edtico<\/th>\nQuimioter\u00e1pico<\/th>\nRisco RSS<\/th>\n<\/tr>\n<\/thead>\n
CRS multivisceral<\/td>\nEndoGIA \u00d7 8-15 + Harmonic + CUSA<\/td>\nN\u00e3o-aplic\u00e1vel<\/td>\nA4 volumoso + RBI<\/td>\n<\/tr>\n
HIPEC 41-43\u00b0C<\/td>\nCircuito Belmont\/Combat R$ 4-12k<\/td>\nCisplatina+mitomicina+oxali Lista C5<\/td>\nA4 + B + EPI qu\u00edmico-t\u00e9rmico<\/td>\n<\/tr>\n
Sugarbaker Coliseum<\/td>\nOpen vs closed abdomen<\/td>\nLavagem peritoneal extensa<\/td>\nA1 + B + biol\u00f3gico<\/td>\n<\/tr>\n
EPIC POD 1-5<\/td>\nCateter intraperitoneal<\/td>\n5-FU+paclitaxel intraperitoneal<\/td>\nA4 + B Lista C5<\/td>\n<\/tr>\n
NIPS neoadjuvante<\/td>\nBev+cetux+panitumumab<\/td>\nAvastin+Erbitux+Vectibix Lista C5<\/td>\nA4 + B Lista C5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 entre R$ 38.000-78.000\/m\u00eas<\/strong> em PGRSS dedicado de colon HIPEC vs R$ 14.000-28.000<\/strong> em PGRSS gen\u00e9rico subdimensionado.<\/p>\n

A CRS multivisceral + Sugarbaker: o procedimento de alt\u00edssima complexidade<\/h2>\n

A primeira camada do desafio \u00e9 a CRS. Padr\u00e3o setorial inclui (a) CRS Cytoreductive Surgery<\/strong> com PCI score 0-39 + meta CC0 (sem doen\u00e7a residual) ou CC1 (<2.5mm); (b) ressec\u00e7\u00e3o multivisceral<\/strong> com peritoneoctomia parietal\/visceral + omentectomia greater+lesser + apendicectomia + colectomia + ressec\u00e7\u00e3o delgado + esplenectomia + colecistectomia + diafragma + ressec\u00e7\u00e3o c\u00e1psula hep\u00e1tica; (c) EndoGIA Tri-Staple Medtronic<\/strong> R$ 800-2k \u00d7 8-15 cartuchos + Endopath Xcel circular CDH<\/strong> R$ 1.500-3.500 + CUSA Cavitron Integra<\/strong> R$ 3-25k consum\u00edvel + bisturi Harmonic ACE \/ LigaSure<\/strong> R$ 3-5k; (d) Sugarbaker open Coliseum technique<\/strong> com retentor abdominal Thompson + circula\u00e7\u00e3o cont\u00ednua de quimioter\u00e1pico aquecido OU closed abdomen<\/strong> com fechamento tempor\u00e1rio; (e) livro RBI cartucho + circular<\/strong> com reten\u00e7\u00e3o 10 anos.<\/p>\n

Hospital com 30-100 CRSs\/ano \u00d7 R$ 25-50k consum\u00edveis = R$ 750k-5M\/ano em CRS + livro RBI. Como discutimos no post sobre PGRSS de p\u00e2ncreas onc<\/a>, tecnovigil\u00e2ncia \u00e9 estruturante.<\/p>\n

O HIPEC + circuito aquecido + EPI N\u00edvel 4: o est\u00e1gio t\u00e9rmico-qu\u00edmico<\/h2>\n

A segunda camada \u00e9 o HIPEC. Padr\u00e3o setorial inclui (a) circuito HIPEC<\/strong> Belmont Hyperthermic Pump \/ Combat Pre-Heat \/ Sunchrise Performer HT \/ RanD Performer R$ 4-12k descart\u00e1vel + bag inflow\/outflow + sensor temp; (b) HIPEC Lista C5<\/strong> cisplatina 50-100mg\/m\u00b2 + mitomicina C 12.5-15mg\/m\u00b2 + oxaliplatina 350-460mg\/m\u00b2 + irinotecano + paclitaxel + doxorrubicina circula\u00e7\u00e3o intraperitoneal aquecido 41-43\u00b0C \u00d7 30-90min; (c) EPI N\u00edvel 4 qu\u00edmico-t\u00e9rmico<\/strong> macac\u00e3o Tyvek + capacete elastom\u00e9rico + face shield + luva nitr\u00edlica 6-8mil + sapatilha; (d) PIPAC Pressurized IntraPeritoneal Aerosol Chemotherapy<\/strong> alternativa minimamente invasiva CapnoPen + nebulizador; (e) descarte espec\u00edfico citost\u00e1tico aquecido<\/strong> com identifica\u00e7\u00e3o espec\u00edfica.<\/p>\n

Hospital com 30-100 HIPECs\/ano \u00d7 R$ 8k circuito + R$ 6k Lista C5 = R$ 420k-1.4M\/ano em HIPEC + EPI N\u00edvel 4 + descarte citost\u00e1tico aquecido.<\/p>\n

O NIPS + EPIC + bev\/cetux\/panitumumab: o est\u00e1gio adjuvante Lista C5<\/h2>\n

A terceira camada \u00e9 o adjuvante. Padr\u00e3o setorial inclui (a) NIPS Neoadjuvant IntraPeritoneal Systemic chemotherapy<\/strong> com FOLFOX+bev pr\u00e9-CRS reduzir PCI; (b) EPIC Early Postoperative Intraperitoneal Chemotherapy<\/strong> com 5-FU paclitaxel intraperitoneal POD 1-5; (c) bevacizumab Avastin<\/strong> Roche anti-VEGF R$ 8-15k\/dose; (d) cetuximab Erbitux<\/strong> Merck + panitumumab Vectibix Amgen anti-EGFR para RAS wild-type Lista C5 R$ 18-25k\/dose; (e) trifluridine\/tipiracil Lonsurf<\/strong> Servier + regorafenib Stivarga 3\u00aa linha CRC metast\u00e1tico.<\/p>\n

Hospital com 100-300 CRCs metast\u00e1ticos\/ano \u00d7 bev+cetux\/panit R$ 10-20k\/m\u00eas \u00d7 12-24 meses = R$ 12-72M\/ano em Lista C5 sist\u00eamica.<\/p>\n

Tr\u00eas perfis de PGRSS para colon HIPEC<\/h2>\n

PGRSS gen\u00e9rico subdimensionado.<\/strong> Sem cobertura espec\u00edfica para HIPEC + EPI N\u00edvel 4 + Lista C5. Custo mensal R$ 14.000-28.000<\/strong>, efic\u00e1cia limitada.<\/p>\n

PGRSS dedicado intermedi\u00e1rio.<\/strong> Cobertura para CRS + HIPEC, sem EPIC + NIPS + targeted. Custo mensal R$ 28.000-52.000<\/strong>, efic\u00e1cia 100-200%.<\/p>\n

PGRSS dedicado completo colon HIPEC.<\/strong> CRS + HIPEC + EPIC + NIPS + bev\/cetux\/panitumumab + integra\u00e7\u00e3o com PGRSS de colorretal<\/a>. Custo mensal R$ 52.000-78.000<\/strong>, ROI 250-500%.<\/p>\n

Os tr\u00eas erros que aparecem em PGRSS colon HIPEC subdimensionado<\/h2>\n

O primeiro \u00e9 o subdimensionamento de Lista C5 HIPEC aquecido<\/strong>. Cisplatina+mitomicina+oxali aquecido 41-43\u00b0C com EPI N\u00edvel 4 + descarte espec\u00edfico citost\u00e1tico.<\/p>\n

O segundo \u00e9 a aus\u00eancia de EPI qu\u00edmico-t\u00e9rmico N\u00edvel 4<\/strong>. HIPEC sem macac\u00e3o Tyvek + capacete elastom\u00e9rico = exposi\u00e7\u00e3o ocupacional + NR-32 violation.<\/p>\n

O terceiro \u00e9 a descarte de circuito Belmont\/Combat como Grupo D<\/strong>. R$ 4-12k circuito \u00e9 tecnovigil\u00e2ncia + RAEE + livro RBI.<\/p>\n

A regula\u00e7\u00e3o de PGRSS no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com colon HIPEC como prioridade. As institui\u00e7\u00f5es que estruturam PGRSS dedicado desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A SBCO Sociedade Brasileira de Cirurgia Oncol\u00f3gica<\/a> \u00e9 refer\u00eancia t\u00e9cnica.<\/p>\n

Solicite cota\u00e7\u00e3o PGRSS de colon HIPEC<\/a><\/strong> \u2014 cap\u00edtulo dedicado a CRS multivisceral + EndoGIA + CUSA, HIPEC Belmont\/Combat\/Sunchrise + cisplatina+mitomicina+oxali Lista C5, Sugarbaker Coliseum + closed abdomen, EPIC + NIPS, bev Avastin + cetux Erbitux + panitumumab Vectibix Lista C5.<\/p>\n","protected":false},"excerpt":{"rendered":"

Colon avan\u00e7ado gera RSS espec\u00edfico \u2014 HIPEC, CRS, Sugarbaker, lavagem peritoneal. PGRSS dedicado.<\/p>\n","protected":false},"author":3,"featured_media":2111,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[2934,2931,2932,2933],"class_list":["post-2112","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-carcinomatose","tag-colon-hipec","tag-crs","tag-sugarbaker"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2112"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2112\/revisions"}],"predecessor-version":[{"id":4281,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2112\/revisions\/4281"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2111"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}